Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by Accountprinceon Dec 29, 2022 9:45am
229 Views
Post# 35195012

RE:Canadian Disclosure Law

RE:Canadian Disclosure LawThanks hmmmmm.  I just looked on Sedar and there is nothing.  So we don't have adequate governance and we don't have adequate disclosure.  These are facts - not opinions.

This is a public company and subject to public company laws.  Time to comply with obligations and requirements.  This is not a voluntary thing it's required.  Any loss that any shareholder bears due to non-disclosure can be recovered from those that have not complied with their statutory duties.

If the guys want to operate as a private company then take this private.  I think GORF is outside the value at $52 a share.  MM is spot on at the $8 to $10 a share.  So far the weak disclosure of Dec 13 press release suggests the company is better off with the Infomed deal so MM valuation may be light if that's true.  The $1.90 per share value is from an insider (Paradigm) that has shown a tight connection to our renegade management.  Thus, any opinion from them must be taken out of the mix as purely biased.

So either treat us with the respect we are due by complying with public company laws or offer us true fair market value if you want to operate as a private company.
<< Previous
Bullboard Posts
Next >>